71
and $10,133, respectively. Assuming a procedural stroke
rate of 0.9% for CEA and 5.0% for CAS, and a 30-day mortality rate of 0% for CEA and 1.2% for CAS, CEA was found
to be associated with a lifetime saving of $7017 per patient and an increase in quality-adjusted life years saved
of 0.16.